TABLE 3

Statistical evaluation of different treatments


Graph

Treatment

Dose OVA (μg), log
1.5
2
3
4
5A Mepyramine + metiamide vs. mepyramine ns ns ns ns
5B Zafirlukast + mepyramine vs. zafirlukast ns —**
5C Diclofenac + mepyramine vs. diclofenac —*** —***
6B Mepyramine + Zafirlukast vs. BAY u3405 ns ns ns
6B Mepyramine + zafirlukast + BAY u3405 vs. BAY u3405 —* —* —***
6B Mepyramine + zafirlukast + BAY u3405 vs. mepyramine + zafirlukast ns ns —*
6C Mepyramine + metiamide vs. BAY x1005 ns ns ns
6C BAY x1005 + mepyramine + metiamide vs. BAY x1005 ns —* —***
6C
BAY x1005 + mepyramine + metiamide vs. mepyramine + metiamide
ns
ns
—***

  • ns, P > 0.02, *P < 0.02, **P < 0.01, ***P < 0.001.